The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children
We studied the neuromuscular blocking effects of rapacuronium (Org 9487) (dose-response curve, onset, and 50% effective dose [ED50] value), and changes in heart rate and blood pressure, as well as evidence of histamine release in neonates, infants, and children in an open-label, randomized, two-cent...
Saved in:
Published in | Anesthesia and analgesia Vol. 89; no. 5; pp. 1172 - 1176 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott
01.11.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We studied the neuromuscular blocking effects of rapacuronium (Org 9487) (dose-response curve, onset, and 50% effective dose [ED50] value), and changes in heart rate and blood pressure, as well as evidence of histamine release in neonates, infants, and children in an open-label, randomized, two-center study. Fifteen neonates, 30 infants, and 30 children were studied. Anesthesia was induced and maintained with propofol, nitrous oxide:oxygen (60:40), and fentanyl. Mechanomyographic monitoring of neuromuscular function was performed at the thumb. The potency (ED50) for neonates, infants, and children were 0.32 (95% confidence interval [CI] 0.15-0.61), 0.28 (95% CI 0.11-0.61), and 0.39 (95% CI 0.17-0.85) mg/kg, respectively. Neonates who received 0.3, 0.6, or 0.9 mg/kg Org 9487 developed a maximum T1 twitch depression of 34 +/-28%, 98 +/- 3%, and 99 +/- 2%, respectively. Time-to-peak effect (onset time) for 0.9 mg/kg Org 9487 was 57 +/- 20 s. Maximum percent T1 twitch depression (+/-SD) in infants who received 0.3, 0.6, or 0.9 mg/kg rapacuronium was 41 +/- 34%, 96 +/- 7%, and 100 +/- 1%, respectively. Time-to-peak effect for 0.9 mg/kg Org 9487 was 62 +/- 29 s. In children 0.3, 0.6, and 0.9 mg/kg rapacuronium resulted in an average percent T1 twitch suppression of 29 +/- 23, 83 +/- 11, and 90 +/- 16, respectively. Time-to-peak effect of 0.9 mg/kg Org 9487 was 96 +/- 33 s, respectively. There was no evidence of histamine release or significant changes in heart rate or blood pressure in either group at any dose. Rapacuronium is a low-potency nondepolarizing muscle relaxant with a fast onset of relaxation and minimal cardiovascular effects. Its potency (ED50) is similar in neonates (0.32 mg/kg), infants (0.28 mg/kg), and children (0.39 mg/kg). T1 suppression (90% +/- 16) is less and time to peak effect (96 +/- 33 s) is greater (0.9 mg/kg rapacuronium) in children, compared with the combined group of infants and neonates.
This study assesses the potency of rapacuronium (Org 9487) in pediatric patients. The potency of rapacuronium is similar in neonates (0.32 mg/kg), infants (0.28 mg/kg), and children (0.39 mg/kg). |
---|---|
AbstractList | We studied the neuromuscular blocking effects of rapacuronium (Org 9487) (dose-response curve, onset, and 50% effective dose [ED50] value), and changes in heart rate and blood pressure, as well as evidence of histamine release in neonates, infants, and children in an open-label, randomized, two-center study. Fifteen neonates, 30 infants, and 30 children were studied. Anesthesia was induced and maintained with propofol, nitrous oxide:oxygen (60:40), and fentanyl. Mechanomyographic monitoring of neuromuscular function was performed at the thumb. The potency (ED50) for neonates, infants, and children were 0.32 (95% confidence interval [CI] 0.15-0.61), 0.28 (95% CI 0.11-0.61), and 0.39 (95% CI 0.17-0.85) mg/kg, respectively. Neonates who received 0.3, 0.6, or 0.9 mg/kg Org 9487 developed a maximum T1 twitch depression of 34 +/-28%, 98 +/- 3%, and 99 +/- 2%, respectively. Time-to-peak effect (onset time) for 0.9 mg/kg Org 9487 was 57 +/- 20 s. Maximum percent T1 twitch depression (+/-SD) in infants who received 0.3, 0.6, or 0.9 mg/kg rapacuronium was 41 +/- 34%, 96 +/- 7%, and 100 +/- 1%, respectively. Time-to-peak effect for 0.9 mg/kg Org 9487 was 62 +/- 29 s. In children 0.3, 0.6, and 0.9 mg/kg rapacuronium resulted in an average percent T1 twitch suppression of 29 +/- 23, 83 +/- 11, and 90 +/- 16, respectively. Time-to-peak effect of 0.9 mg/kg Org 9487 was 96 +/- 33 s, respectively. There was no evidence of histamine release or significant changes in heart rate or blood pressure in either group at any dose. Rapacuronium is a low-potency nondepolarizing muscle relaxant with a fast onset of relaxation and minimal cardiovascular effects. Its potency (ED50) is similar in neonates (0.32 mg/kg), infants (0.28 mg/kg), and children (0.39 mg/kg). T1 suppression (90% +/- 16) is less and time to peak effect (96 +/- 33 s) is greater (0.9 mg/kg rapacuronium) in children, compared with the combined group of infants and neonates.
This study assesses the potency of rapacuronium (Org 9487) in pediatric patients. The potency of rapacuronium is similar in neonates (0.32 mg/kg), infants (0.28 mg/kg), and children (0.39 mg/kg). UNLABELLEDWe studied the neuromuscular blocking effects of rapacuronium (Org 9487) (dose-response curve, onset, and 50% effective dose [ED50] value), and changes in heart rate and blood pressure, as well as evidence of histamine release in neonates, infants, and children in an open-label, randomized, two-center study. Fifteen neonates, 30 infants, and 30 children were studied. Anesthesia was induced and maintained with propofol, nitrous oxide:oxygen (60:40), and fentanyl. Mechanomyographic monitoring of neuromuscular function was performed at the thumb. The potency (ED50) for neonates, infants, and children were 0.32 (95% confidence interval [CI] 0.15-0.61), 0.28 (95% CI 0.11-0.61), and 0.39 (95% CI 0.17-0.85) mg/kg, respectively. Neonates who received 0.3, 0.6, or 0.9 mg/kg Org 9487 developed a maximum T1 twitch depression of 34 +/-28%, 98 +/- 3%, and 99 +/- 2%, respectively. Time-to-peak effect (onset time) for 0.9 mg/kg Org 9487 was 57 +/- 20 s. Maximum percent T1 twitch depression (+/-SD) in infants who received 0.3, 0.6, or 0.9 mg/kg rapacuronium was 41 +/- 34%, 96 +/- 7%, and 100 +/- 1%, respectively. Time-to-peak effect for 0.9 mg/kg Org 9487 was 62 +/- 29 s. In children 0.3, 0.6, and 0.9 mg/kg rapacuronium resulted in an average percent T1 twitch suppression of 29 +/- 23, 83 +/- 11, and 90 +/- 16, respectively. Time-to-peak effect of 0.9 mg/kg Org 9487 was 96 +/- 33 s, respectively. There was no evidence of histamine release or significant changes in heart rate or blood pressure in either group at any dose. Rapacuronium is a low-potency nondepolarizing muscle relaxant with a fast onset of relaxation and minimal cardiovascular effects. Its potency (ED50) is similar in neonates (0.32 mg/kg), infants (0.28 mg/kg), and children (0.39 mg/kg). T1 suppression (90% +/- 16) is less and time to peak effect (96 +/- 33 s) is greater (0.9 mg/kg rapacuronium) in children, compared with the combined group of infants and neonates.IMPLICATIONSThis study assesses the potency of rapacuronium (Org 9487) in pediatric patients. The potency of rapacuronium is similar in neonates (0.32 mg/kg), infants (0.28 mg/kg), and children (0.39 mg/kg). |
Author | SLAVEN, J. S TSAI, K.-T KAPLAN, R. F DARROW, E. J FLETCHER, J. E HANNALLAH, R. S BUI, D. T |
Author_xml | – sequence: 1 givenname: R. F surname: KAPLAN fullname: KAPLAN, R. F organization: Department of Anesthesiology, Children's National Medical Center, Washington, DC, United States – sequence: 2 givenname: J. E surname: FLETCHER fullname: FLETCHER, J. E organization: Department of Anesthesiology, Children's Hospital of Buffalo, Buffalo, New York, United States – sequence: 3 givenname: R. S surname: HANNALLAH fullname: HANNALLAH, R. S organization: Department of Anesthesiology, Children's National Medical Center, Washington, DC, United States – sequence: 4 givenname: D. T surname: BUI fullname: BUI, D. T organization: Department of Anesthesiology, Children's Hospital of Buffalo, Buffalo, New York, United States – sequence: 5 givenname: J. S surname: SLAVEN fullname: SLAVEN, J. S organization: Department of Anesthesiology, Children's National Medical Center, Washington, DC, United States – sequence: 6 givenname: E. J surname: DARROW fullname: DARROW, E. J organization: Department of Anesthesiology, Children's National Medical Center, Washington, DC, United States – sequence: 7 givenname: K.-T surname: TSAI fullname: TSAI, K.-T organization: Department of Biometrics, Organon, Inc., West Orange, New Jersey, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1178848$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10553829$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkdtuFSEUhompsbvVVzBcGNMmojDMDHBpaj0kTXpTrydrYNGNmQ0jzBj7ML6r7O7tgYTAIt-_Dvxn5CSmiIRQwd8KbtQ7vl-dNEwYY4SoAatb9E_IRnRNz1Rn9AnZ1DfJmoqckrNSvu0Rrvtn5FTwrpO6MRvy626LdE4LRvtAL64_dPySQnTUQnYh_YBi1wkyRe_RLoUmTzPMYNecYlh39OI231PTanVJ3ZpDvKcRsk1LsCyGJae1Sn4Gh2zOaU4-TTU5lmWLJQANkUZMERYsb2rgIS718lh9GyaXMT4nTz1MBV8cz3Py9eP13dVndnP76cvV-xtmG6l6JnvubD8652wdVokWlETZKcvVOLbSyQYAUVoutOAoR4BWWD1ybdvG6s7Lc_L6kLe2-X2tDQ67UCxOU-22zjD0pmlFa2QF9QG0OZWS0Q9zDjvID4Pgw96a4Y81w19rhkdrqvTlscY67tD9Jzx4UYFXR6D-Okw-Q7Sh_OOE0rrV8jcgRJmE |
CODEN | AACRAT |
CitedBy_id | crossref_primary_10_1097_00001503_200008000_00013 crossref_primary_10_1046_j_1460_9592_2001_00732_x |
Cites_doi | 10.1097/00000539-199512001-00002 10.1097/00000542-199706000-00010 10.5694/j.1326-5377.1990.tb124423.x 10.1097/00000542-199612000-00006 10.1183/09031936.96.09071356 10.1002/(SICI)1099-0496(199712)24:6<423::AID-PPUL7>3.0.CO;2-H 10.1183/09031936.93.04101275 10.1093/bja/77.6.739 10.1152/jappl.1993.74.1.369 10.1097/00000542-199501000-00006 10.1001/jama.1992.03490190073034 10.1111/j.1365-2044.1996.tb12635.x 10.1213/00000539-199109000-00017 10.1152/jappl.1987.63.2.546 10.1007/BF03011308 10.1213/00000539-199411000-00004 10.1203/00006450-199303000-00011 10.1093/bja/67.4.387 10.1097/00000542-199709000-00019 10.1007/BF03013033 |
ContentType | Journal Article |
Copyright | 2000 INIST-CNRS |
Copyright_xml | – notice: 2000 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1097/00000539-199911000-00016 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1526-7598 |
EndPage | 1176 |
ExternalDocumentID | 10_1097_00000539_199911000_00016 10553829 1178848 |
Genre | Multicenter Study Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .55 .GJ .XZ .Z2 01R 026 08R 0R~ 1CY 1J1 23M 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAXR AAGIX AAHPQ AAJCS AAMOA AAMTA AAPBV AAQKA AAQQT AARTV AASOK AAUGY AAWTL AAXQO ABASU ABBUW ABDIG ABKPX ABOCM ABPPZ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLED ACWDW ACWRI ACXNZ ADBBV ADFPA ADGGA ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFFNX AFMFG AFUWQ AGINI AHOMT AHRYX AHVBC AHXIK AIJEX AJIOK AJNWD AJNYG AJRGT AKALU AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BAWUL BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GNXGY GQDEL GX1 H0~ HZ~ IKREB IKYAY IN~ IPNFZ IQODW J5H JF9 JG8 JK3 JK8 K8S KD2 KMI L-C L7B M18 MZP N4W N9A N~7 N~B N~M O9- OAG OAH OB4 OCUKA ODA ODMTH OHYEH OJAPA OK1 OL1 OLG OLH OLL OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PONUX R58 RIG RLZ S4R S4S TEORI TR2 TSPGW TWZ V2I VVN W3M W8F WOQ WOW X3V X3W X7M XXN XYM YFH YOC YQJ ZA5 ZFV ZGI ZXP ZZMQN AAAAV AAIQE AASCR AAUEB ABJNI ABVCZ ACLDA ACXJB ADHPY AFEXH AFSOK AHQNM AINUH AJZMW CGR CUY CVF ECM EIF ERAAH HLJTE NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c2376-360dc6bdddc999714a73e357c07bb43d32aaee3c01810e3baa41c8b08c42c85f3 |
ISSN | 0003-2999 |
IngestDate | Wed Dec 04 10:03:23 EST 2024 Thu Nov 21 23:46:38 EST 2024 Tue Oct 15 23:20:17 EDT 2024 Sun Oct 29 17:08:38 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human Fentanyl General anesthesia Infant Opiates Narcotic analgesic Rapacuronium bromide Dose activity relation Gases Histamine Non depolarisant myorelaxant Newborn General anesthetic Hemodynamics Propofol Nitrogen protoxide Child Neuromuscular blocking Release |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2376-360dc6bdddc999714a73e357c07bb43d32aaee3c01810e3baa41c8b08c42c85f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-News-3 content type line 23 |
OpenAccessLink | https://doi.org/10.1097/00000539-199911000-00016 |
PMID | 10553829 |
PQID | 69241493 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_69241493 crossref_primary_10_1097_00000539_199911000_00016 pubmed_primary_10553829 pascalfrancis_primary_1178848 |
PublicationCentury | 1900 |
PublicationDate | 1999-Nov |
PublicationDateYYYYMMDD | 1999-11-01 |
PublicationDate_xml | – month: 11 year: 1999 text: 1999-Nov |
PublicationDecade | 1990 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Anesthesia and analgesia |
PublicationTitleAlternate | Anesth Analg |
PublicationYear | 1999 |
Publisher | Lippincott |
Publisher_xml | – name: Lippincott |
References | Hewlett (R19-16) 1974; 46 Rooke (R17-16) 1997; 86 Chang (R26-16) 1981; 51 Naito (R1-16) 1991; 67 Carman (R7-16) 1990; 152 Kondo (R25-16) 1997; 24 Lanteri (R23-16) 1993; 74 Doi (R4-16) 1993; 40 Holzman (R6-16) 1996; 85 Freezer (R16-16) 1993; 33 Habre (R10-16) 1997; 87 Nunn (R18-16) 1990; 65 Kochi (R20-16) 1991; 73 Meretoja (R15-16) 1996; 76 Barnes (R9-16) 1986; 134 Lanteri (R24-16) 1995; 95 Hall (R21-16) 1996; 51 Nicolai (R12-16) 1991; 4 Gautier (R22-16) 1987; 63 Weitzman (R8-16) 1992; 268 Inomata (R11-16) 1996; 43 Habre (R13-16) 1996; 77 Ponsonby (R27-16) 1996; 9 Lerman (R2-16) 1995; 81 Piat (R5-16) 1994; 79 Sarner (R3-16) 1995; 82 |
References_xml | – volume: 81 start-page: S4???10 year: 1995 ident: R2-16 publication-title: Anesth Analg doi: 10.1097/00000539-199512001-00002 contributor: fullname: Lerman – volume: 86 start-page: 1294???9 year: 1997 ident: R17-16 publication-title: Anesthesiology doi: 10.1097/00000542-199706000-00010 contributor: fullname: Rooke – volume: 152 start-page: 23???6 year: 1990 ident: R7-16 publication-title: Med J Aust doi: 10.5694/j.1326-5377.1990.tb124423.x contributor: fullname: Carman – volume: 46 start-page: 486???94 year: 1974 ident: R19-16 publication-title: Br J Anaesth contributor: fullname: Hewlett – volume: 85 start-page: 1260???7 year: 1996 ident: R6-16 publication-title: Anesthesiology doi: 10.1097/00000542-199612000-00006 contributor: fullname: Holzman – volume: 9 start-page: 1356???62 year: 1996 ident: R27-16 publication-title: Eur Respir J doi: 10.1183/09031936.96.09071356 contributor: fullname: Ponsonby – volume: 24 start-page: 423???8 year: 1997 ident: R25-16 publication-title: Pediatr Pulmonol doi: 10.1002/(SICI)1099-0496(199712)24:6<423::AID-PPUL7>3.0.CO;2-H contributor: fullname: Kondo – volume: 4 start-page: 1275???83 year: 1991 ident: R12-16 publication-title: Eur Respir J doi: 10.1183/09031936.93.04101275 contributor: fullname: Nicolai – volume: 77 start-page: 739???43 year: 1996 ident: R13-16 publication-title: Br J Anaesth doi: 10.1093/bja/77.6.739 contributor: fullname: Habre – volume: 95 start-page: 29???45 year: 1995 ident: R24-16 publication-title: Pediatr Pulmonol contributor: fullname: Lanteri – volume: 74 start-page: 369???78 year: 1993 ident: R23-16 publication-title: J Appl Physiol doi: 10.1152/jappl.1993.74.1.369 contributor: fullname: Lanteri – volume: 82 start-page: 38???46 year: 1995 ident: R3-16 publication-title: Anesthesiology doi: 10.1097/00000542-199501000-00006 contributor: fullname: Sarner – volume: 268 start-page: 2673???7 year: 1992 ident: R8-16 publication-title: JAMA doi: 10.1001/jama.1992.03490190073034 contributor: fullname: Weitzman – volume: 51 start-page: 890 year: 1996 ident: R21-16 publication-title: Anaesthesia doi: 10.1111/j.1365-2044.1996.tb12635.x contributor: fullname: Hall – volume: 73 start-page: 327???32 year: 1991 ident: R20-16 publication-title: Anesth Analg doi: 10.1213/00000539-199109000-00017 contributor: fullname: Kochi – volume: 51 start-page: 218???25 year: 1981 ident: R26-16 publication-title: J Appl Physiol contributor: fullname: Chang – volume: 63 start-page: 546???53 year: 1987 ident: R22-16 publication-title: J Appl Physiol doi: 10.1152/jappl.1987.63.2.546 contributor: fullname: Gautier – volume: 40 start-page: 122???6 year: 1993 ident: R4-16 publication-title: Can J Anaesth doi: 10.1007/BF03011308 contributor: fullname: Doi – volume: 79 start-page: 840???4 year: 1994 ident: R5-16 publication-title: Anesth Analg doi: 10.1213/00000539-199411000-00004 contributor: fullname: Piat – volume: 33 start-page: 261???6 year: 1993 ident: R16-16 publication-title: Pediatr Res doi: 10.1203/00006450-199303000-00011 contributor: fullname: Freezer – volume: 65 start-page: 54???62 year: 1990 ident: R18-16 publication-title: Br J Anaesth contributor: fullname: Nunn – volume: 67 start-page: 387???9 year: 1991 ident: R1-16 publication-title: Br J Anaesth doi: 10.1093/bja/67.4.387 contributor: fullname: Naito – volume: 76 start-page: 767???71 year: 1996 ident: R15-16 publication-title: Br J Anaesth contributor: fullname: Meretoja – volume: 134 start-page: 1289???314 year: 1986 ident: R9-16 publication-title: Am Rev Respir Dis contributor: fullname: Barnes – volume: 87 start-page: 585???90 year: 1997 ident: R10-16 publication-title: Anesthesiology doi: 10.1097/00000542-199709000-00019 contributor: fullname: Habre – volume: 43 start-page: 806???11 year: 1996 ident: R11-16 publication-title: Can J Anaesth doi: 10.1007/BF03013033 contributor: fullname: Inomata |
SSID | ssj0001086 |
Score | 1.6244303 |
Snippet | We studied the neuromuscular blocking effects of rapacuronium (Org 9487) (dose-response curve, onset, and 50% effective dose [ED50] value), and changes in... UNLABELLEDWe studied the neuromuscular blocking effects of rapacuronium (Org 9487) (dose-response curve, onset, and 50% effective dose [ED50] value), and... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 1172 |
SubjectTerms | Anesthesia Anesthetics, Inhalation Anesthetics, Intravenous Anesthetics. Neuromuscular blocking agents Biological and medical sciences Blood Pressure - drug effects Child Child, Preschool Dose-Response Relationship, Drug Heart Rate - drug effects Histamine Release - drug effects Humans Infant Infant, Newborn Medical sciences Neuromuscular Blockade Neuromuscular Nondepolarizing Agents - administration & dosage Neuropharmacology Nitrous Oxide Pharmacology. Drug treatments Propofol Prospective Studies Vecuronium Bromide - administration & dosage Vecuronium Bromide - analogs & derivatives |
Title | The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10553829 https://search.proquest.com/docview/69241493 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKeEFCCMS_AgM_8LApS5XUiRM_QtcxgSjT6KS9VbbjTJFKW3WphPgufDy-B3d2_nUqAvYSNa5ip75fz-fz7-4IeTuMZcCVED4PhPYjOZS-SDTc6txwxQIlEwxw_jzhpxfRx8v4stf71WEtbUo10D92xpXcRqrQBnLFKNn_kGzTKTTAZ5AvXEHCcP1nGZ8tSxs9CZbi-DgOcJePvvDRNs903NI2zmF51BtMibv5ZpONrq88EVmfgHfsghYngP4ljOZPinKNHNkv34vM-GdYUSFfgkxBP4LheF1IdJdMDHrga3WTS8vMcJzQURUq3jWBOw-7RLFYaeS6aJaHT3I1l92gf-9ksAtllt_rjQetDsVc0HNp_UTnUuay9L42377fFA2F35sOWmeHTZAQNs6OWoFj6TlXU6lW4K4GUQXUuKONw9CVBapWdrjlO1cNl43Y7pdiJpB7IzCTng25D3ck6r6xgDa0xs6Bvu1p1vRkz_j5HXIX8zViiYcPly0TCYtd1YUd8bdVhLM6t-iud9qyou6vAExynrtKLH_eKlmTafqQPKj2OvSdA-4j0jOLx-QngJZWoKUHCNlDCjig24ClFWDpMqddwNIDgCtFuB5SB1Z6E6x0G6y0xRstFrQG6xGtoHrkRq-A-oRcnIyno1O_qhHia-Rz-YwHmeYqyzINM5SEkUyYYXGig0SpiGVsKKUxTGNeusAwJWUU6lQFqY6GOo1z9pTsLZYL85xQLuI0UQz2M1JEIpEKrG8BLVymjCuu-iSs53y2cqlgZn-TeJ_sbwmnfTBM0jRK--RNLawZ6HU8rJMLA3M144CTMBKsT545GXbGjMFKGYoXt3ifl-Re-7d6RfbK9cbsg1VdqtcWk78BTnHAcw |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Potency+%28ED50%29+and+Cardiovascular+Effects+of+Rapacuronium+%28Org+9487%29+During+Narcotic-Nitrous+Oxide-Propofol+Anesthesia+in+Neonates%2C+Infants%2C+and+Children&rft.jtitle=Anesthesia+and+analgesia&rft.au=Kaplan%2C+Richard+F.&rft.au=Fletcher%2C+James+E.&rft.au=Hannallah%2C+Raafat+S.&rft.au=Bui%2C+David+T.&rft.date=1999-11-01&rft.issn=0003-2999&rft.volume=89&rft.issue=5&rft.spage=1172&rft.epage=1176&rft_id=info:doi/10.1097%2F00000539-199911000-00016&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_00000539_199911000_00016 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-2999&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-2999&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-2999&client=summon |